Snakebite envenomation in children: An ongoing burden in Morocco
Authors:
Open Access
- 2 April 2022
- journal article
- research article
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 77, 103574
Abstract
Snakebites are a leading cause of mortality and permanent disabilities especially among children in tropical countries and rural areas such as Morocco. Thus, a nationwide management protocol including specific antivenom therapy along with prevention strategies was implemented to reduce the overall snakebites morbimortality. Our retrospective study aimed to describe the clinical aspects of snakebite envenomation before and after the implementation of this protocol in children admitted to the pediatric intensive care unit (PICU) in Marrakesh-Morocco for a period of 11 years. A total of 75 cases were included and were mostly male (70%) with a mean age of 10 years old. Most envenomations were mild or severe (75%) and often occurred during outdoor activities in limb extremities. Altered hemostasis frequently occurred in 67% of cases but was rarely associated with severe exteriorized hemorrhage. Moderate anemia and PNN- predominant leukocytosis were often observed at admission (52.2% and 58%) but quickly tended to normalize before 48 h. Local symptoms were the main dread as they quickly evolve to a compartment syndrome and necrosis in the absence of antivenom therapy. Fasciotomy was performed in 33% of cases while 5 children required limb amputation. Antivenom administration (n = 39) was statistically significant for rapid improvement in hemostasis disorders, reduced blood transfusions and fasciotomy for compartment syndrome as well as a shortened length of stay in PICU. The onset of acute kidney injury was observed in 18 cases but restored in most patients within 48 h (77%). Five children died of which only two had received delayed antivenom immunotherapy due to its unavailability and deferred hospital admission. The advent of specific serotherapy has made it possible to optimize the management of patients and to prevent and treat local and systemic complications thus improving the overall prognosis; nevertheless, primary prevention remains the key to reducing snakebites morbimortality.Keywords
This publication has 16 references indexed in Scilit:
- Vulnerability to snakebite envenoming: a global mapping of hotspotsThe Lancet, 2018
- The Epidemiology, Clinical Course, and Management of Snakebites in the North American Snakebite RegistryJournal of Medical Toxicology, 2017
- Predictors of the development of post-snakebite compartment syndromeScandinavian Journal of Trauma, Resuscitation and Emergency Medicine, 2015
- Epidemiological characteristics, hospital course and outcome of snakebite victims in West TexasHospital Practice, 2015
- Cost-effectiveness of Antivenoms for Snakebite Envenoming in NigeriaPLOS Neglected Tropical Diseases, 2015
- Evaluation of a new polyvalent antivenom against snakebite envenomation (Inoserp® Panafricain) in two different epidemiological settings: Northern Benin and Maritime GuineaMedecine Et Sante Tropicales, 2015
- Épidémiologie des envenimations vipérines en réanimation pédiatrique à l’hôpital d’enfants de Marrakech (Maroc)Archives de Pédiatrie, 2014
- Unified treatment algorithm for the management of crotaline snakebite in the United States: results of an evidence-informed consensus workshopBMC Emergency Medicine, 2011
- Characterisation of some pharmacological effects of the venom from Vipera lebetinaToxicon, 2004
- Viper Bites in France: Clinical and Biological Evaluation; Kinetics of EnvenomationsHuman & Experimental Toxicology, 1994